Evidence map›Paper›PMID 39937397›Full record

ArticleBreast cancer research and treatment2025

Racial and ethnic disparities in conversion to mastectomy following lumpectomy.

Jasmine A Khubchandani, Madhav Kc, Pranam Dey, Ellie M Proussaloglou, Monica G Valero, Elizabeth Berger, Tristen Park, Cary P Gross, Paris D Butler, Oluwadamilola M Fayanju and 3 more

Abstract read
In one paragraph

Article in Breast cancer research and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jasmine A KhubchandaniNational Clinician Scholars Program, Yale School of Medicine, New Haven, CT, USA. jasminekhubchandani@gmail.com.
Madhav KcYale Cancer Outcomes, Public Policy, and Effectiveness Research Center (COPPER), Yale School of Medicine, New Haven, CT, USA.
Pranam DeyDepartment of Surgery, Yale School of Medicine, New Haven, CT, USA.
Ellie M ProussaloglouYale Cancer Outcomes, Public Policy, and Effectiveness Research Center (COPPER), Yale School of Medicine, New Haven, CT, USA.
Monica G ValeroDepartment of Surgery, Yale School of Medicine, New Haven, CT, USA.
Elizabeth BergerYale Cancer Outcomes, Public Policy, and Effectiveness Research Center (COPPER), Yale School of Medicine, New Haven, CT, USA.
Tristen ParkDepartment of Surgery, Yale School of Medicine, New Haven, CT, USA.
Cary P GrossYale Cancer Outcomes, Public Policy, and Effectiveness Research Center (COPPER), Yale School of Medicine, New Haven, CT, USA.
Paris D ButlerDepartment of Surgery, Yale School of Medicine, New Haven, CT, USA.
Oluwadamilola M FayanjuDepartment of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Eric P WinerYale Cancer Center, New Haven, CT, USA.
Mehra GolshanDepartment of Surgery, Yale School of Medicine, New Haven, CT, USA.
Rachel A GreenupYale Cancer Outcomes, Public Policy, and Effectiveness Research Center (COPPER), Yale School of Medicine, New Haven, CT, USA.

Funding

Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI Eric P. Winer · 1985 to 2026
$85.0M
NRSA Training CoreTL1TR001864 · NCATS · YALE UNIVERSITY · PI CANTLEY, LLOYD G, EDELMAN, E. JENNIFER · 2016 to 2025
$9.9M
Effectiveness and implementation of a decision support tool to improve surgical decision making in young women with breast cancerR01CA256877 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI GREENUP, RACHEL ADAMS, ROSENBERG, SHOSHANA M · 2022 to 2025
$2.9M
NCATS NIH HHS TL1 TR001864NCI NIH HHS 1R01CA256877-01A1NCI NIH HHS P30 CA016359NCI NIH HHS R01 CA256877
6 · The paper itself

Abstract

purposeAdvances in contemporary breast cancer care (e.g., early detection, increased use of preoperative chemotherapy, and updated SSO-ASTRO margin guidelines) have the collective potential to influence successful breast conservation. We evaluated contemporary trends in conversion to mastectomy (lumpectomy followed by definitive mastectomy) among women with breast cancer undergoing initial lumpectomy.

methodsWomen with unilateral clinical stage 0-III breast cancer were identified from the National Cancer Database (2009-2019). Treatment sequence was categorized into surgery first or neoadjuvant chemotherapy (NACT) followed by surgery. We used a multivariable logistic regression model to calculate the predicted probability of conversion to mastectomy across diagnosis year and race and ethnicity, controlling for socio-demographic and clinical factors. We then calculated the relative change in conversion to mastectomy over time for each race and ethnic group.

resultsThe study included N = 1,543,702 women. Approximately 9.2% received NACT. Conversion to mastectomy differed significantly between those who underwent surgery first (10.6%) versus women who received NACT (6.1%, p < 0.0001). For those who underwent surgery first, success of breast conservation differed significantly by race/ethnicity. During the study period, White women had a relative decrease of 7.6% (95% CI - 10.58, - 4.59), while Black women had a relative increase of 8.9% (95% CI 1.53, 16.19) in predicted probability of conversion to mastectomy.

conclusionOver the past decade, Black women deemed candidates for initial lumpectomy were more likely to be converted to mastectomy when compared to White women. A greater understanding of contributing factors is needed to improve disparities in successful breast conservation.

Indexed as

Breast NeoplasmsHealthcare DisparitiesMastectomyMastectomy, SegmentalAdultAgedEthnicityFemaleHumansMiddle AgedNeoadjuvant TherapyRacial GroupsUnited StatesConversion to mastectomyHealth equityRacial and ethnic disparitiesReturn to OR

Identifiers

PMID39937397
PMCPMC12303253

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.